Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Tekcapital Plc LSE:TEK London Ordinary Share GB00BKXGY798 ORD �0.004
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 15.00 14.00 15.50 15.00 14.25 15.00 449,675 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 5.4 3.6 8.1 2.1 20

Tekcapital Share Discussion Threads

Showing 1751 to 1773 of 1775 messages
Chat Pages: 71  70  69  68  67  66  65  64  63  62  61  60  Older
DateSubjectAuthorDiscuss
14/6/2021
10:16
NAV 23p but current share price 14.85. What a gap!
1choip
10/6/2021
19:26
After the 12m lock in and with agreement with BELL if before 24m
mr.oz
10/6/2021
15:52
wonder when will distribute special dividend after latest IPO
1choip
10/6/2021
14:39
ShareSoc webinar link: hTTps://www.youtube.com/watch?v=zvKZIQd66BQ
ptolemy
09/6/2021
08:16
Missed the webinar due to last minute commitment - did anyone see and if so, how did it go?
joe say
08/6/2021
22:14
Did anyone tune in for the webinar?
r9505571
08/6/2021
22:10
---- India to act on Sodium Sugar and Fat FOPL within months ----- India is making it mandatory to put the quantitites of Sodium Sugar and Fat PER SERVING on the front of packet labels in November 2021 htTps://economictimes.indiatimes.com/industry/cons-products/food-packs-to-have-info-on-salt-sugar-and-fat-per-serving/articleshow/83215164.cms buywell has posted here regarding the links of Salt and Obesity India now has the second worst rate of Child Obesity in the world , which is another reason that authorities are now having to take urgent action This is a recent development and attributed to a shift towards the wrong type of processed foods containing too much sat sugar and fat htTps://www.bignewsnetwork.com/news/269677256/experts-discuss-alarming-rise-in-childhood-obesity There is also now compelling data that connects Salt to Diabetes hTtps://www.msn.com/en-us/health/nutrition/the-surprising-effect-reducing-sodium-may-have-on-your-blood-sugar-new-study-says/ar-AAKK4Za?ocid=BingNewsSearch Diabetes prevalence has increased by 64% across India over the the last 25 years. According to International Diabetes Federation, India’s diabetes population totalled 77 million in 2018 and it is estimated to reach 134.3 million people by 2045. India is the second most country affected by diabetes in the world after China. The link between Obesity and Diabetes and Covid-19 has since emerged following the above rise in India of obesity and diabetes cases leading to the present Pandemic The action now to be taken by India regarding FOPL should be a seen as a valuable lesson to other nations hooked on too much salt sugar and fat in their diets Such mandatory FOPL actions are IMO now likely to follow the lead of a Covid-19 ravaged India as ANYTHING to reduce Obesity must be seen as beneficial in the light of their recent trials Then there is this very recent finding hTtps://www.verywellhealth.com/sodium-affects-immune-health-5184634 dyor imo
buywell2
02/6/2021
08:48
We are hosting a webinar with TekCapital on the 8th June which may be of interest to current shareholders and potential investors. Cliff Gross (CEO) gives the latest updates: hTTps://www.sharesoc.org/events/sharesoc-webinar-with-tekcapital-plc-tek8-june-2021/
sharesoc
31/5/2021
23:43
---- Why put LUCYD Loud links on the new Lucyd Website ??? ---- buywell can't see the point of including links to olde news about Lucyd Loud glasses which compared to Lucyd lite are basically ugly and clunky looking. Besides which are they not no longer stocked or sold ? These links need removing ASAP IMO and from a sales perspective it does not say much that they are currently on the website buywell refers to the : In the Press links Cult of Magic iMore iPhoneLife TechPluto New York Post USA Today Forbes In fact nearly all of the links talk about an old now defunct product the Lucyd Loud buywell thinks this is NOT a good idea --- links that only talk about current products that are on sale please htTs://www.lucyd.com dyor
buywell2
31/5/2021
21:31
---- The eyes and Covid-19 - Study finds wearing glasses reduces risk ----- One for Lucyd perhaps to ponder It is a fact that Covid-19 can enter the body via the eye as well as being breathed in htTps://www.ajmc.com/view/ophthalmology-overview-covid-19-infection-in-eye-cells-vision-loss-and-blindness-prevalence-and-more So it is not surprising that a study found that wearers of eye glasses for longer than 8hrs a day were less prone to catch Covid-19 Further bigger studies should be looked at imo --- with the obvious inference that it would most likely be better to wear PLAIN lenses in eye glasses than no glasses at all for people that did not need to wear prescription glasses ie EVERYBODY Also closer fitting frame shapes would imo help So an extension in the thinking , a bit like wearing masks to give one a better chance of not catching Covid by inhalation The study was published Sept 16th 2020 and titled: Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection hTtps://jamanetwork.com/journals/jamaophthalmology/fullarticle/2770872 imo dyor
buywell2
31/5/2021
00:45
AIM Market Rule 7 states: Special conditions for certain applicants Lock-ins for new businesses. Where an applicant’s main activity is a business which has not been independent and earning revenue for at least two years, it must ensure that all related parties and applicable employees as at the date of admission agree not to dispose of any interest in its securities for one year from the admission of its securities. This rule will not apply in the event of an intervening court order, the death of a party who has been subject to this rule or in respect of an acceptance of a takeover offer for the AIM company which is open to all shareholders. It would thus appear that TEK are locked in to BELL for 12 months as of last friday Whilst some might have been looking for a quick special dividend from TEK's shareholding in BELL --- imo 12 months down the road BELL shares have the potential imo to be trading higher The reason being as buywell has said on here and other advfn threads is the emergence of new mutated variant strains of Covid-19 in an ever more speedy fashion in the event of zero aerosol disinfection measures in indoor spaces A new Vietnam variant and a new Thailand variant have now been discovered It would seem that these new variants are becoming hybrid mutations Strains that contain DNA from two or more existing strains seem to be the way that SARS-CoV-2 is evolving in order to stay alive. buywell read a report regarding the efficacy of the India variant B.1617.2 which looks set to become the next world dominant strain and replace the UK variant , which is still itself causing havoc. A study concluded looking at this India variant and the use of the astrazeneca and pfizer vaccines that : After the first dose --- both gave 33% efficacy against the India variant After the second dose -- the astrazeneca efficacy went up to 60% After the second dose -- the pfizer efficacy went up to 88% hTtps://www.webmd.com/vaccines/covid-19-vaccine/news/20210525/pfizer-astrazeneca-vaccines-indian-variant-study buywell concludes that in the future new studies will be needed against each new variant of concern (VOC) which demonstrates which vaccine performs best One wonders if that will ever happen ? buywell unfortunately concludes it won't as authorities want to use what they have got and quick to try to minimize further aerosol spread --- when in fact they should be looking at ways to kill such mutations and viruses in the air that we breathe indoors , within seconds . Till that happens the case numbers will rack up and the list of organ damaged long COVID suffers will continue to grow --- as will the demand for home oxygen therapy imo dyor
buywell2
29/5/2021
22:50
Belluscura had a successful AIM market debut last Friday Launched at 45p and oversubscribed , it finished the day at 53p with 2.78 Million shares traded The Tekcapital book value last attributed to Belluscura was $2 Million in Nov 2020 At 45p a share the IPO float the actual value of TEK owned BELL shares was $10.8 Million Needless to say the discount to the last published TEK asset value of US 35 cents a share prior to the Belluscura IPO ( $2M valuation ) will likely soon be revised and some additional substance/proof, that some folks have cited/questioned regarding previous valuations of the 4 main developed/developing TEK owned companies --- has been answered in the best way possible ---- by Mr Market himself Indeed the fact that at fridays close the BELL share price represented a 600% uplift on the TEK previous booked valuation ---- might mean that their valuations of the other 3 unlisted companies might be of a similar conservative valuations. One would expect an imminent revaluation of TEK assets to be forthcoming in the order of 45 cents a share TEK are locked in to their Belluscura holding for 12 months under AIM rule 7 Within the next few months there should be considerable newsflow from Belluscura (BELL) regarding new distributors ( 3 signed to date ) and licensed manufacturers of Belluscura products ( 2 signed buywell believes), both are USA based, with a history medical products manufacturing experience and the required quality and other US accreditations in place. Positive RNS oxygen concentrator newsflow from BELL --- one would imagine in the current Covid-19 affected environment --- might well help the share price move higher Especially as Belluscura now sits on a big cash pile compared the the previous cash it has managed to use so well to date There are also many other opportunities that Belluscura can license its patented technologies to --- buywell believes that discussions regarding such have been ongoing for several months. dyor imo
buywell2
28/5/2021
14:03
29/05 FT still showing on profile page About the company Belluscura Ltd is a United Kingdom-based company that manufactures and distributes medical devices. The Company’s products include Wire Caddy, Slyde and Passport. Wire Caddy’s positioning allows access to lubricated guidewires during surgical procedures in interventional radiology, catheterization laboratory, vascular suite and operating room operations. Slyde is a compact and patient evacuation sled for moving immobile patients by pulling up and down stairs in the case of fire, natural disasters, attacks or other emergencies. Passport is used as the access point for the endoscope, which allows the surgeon to visualize the procedure site.
buywell2
28/5/2021
12:34
Yep. Mind the GAP. I guess if the story is as good as we hope it is worth still topping up. I have only bought in since end of last week so my average is about 15.5p when I heard about the IPO. Does anyone have a medium term price target for this over 6months to a year? Or perhaps with such a small cap stock that is a tricky thing to work out.
scooper72
28/5/2021
12:05
The difference between bid and offer share price is now larger than ever though I have slightly increased my holding.
maytrees
28/5/2021
10:49
Highlights: • Belluscura plc has announced the completion of its IPO and the Company shares have been admitted to the AIM market of the London Stock Exchange today. Total funds raised were £17.5m. • Prior to completion of the IPO, TEK held 23.05% of Belluscura, or 17.1m shares. Following the fundraise associated with the IPO TEK now holds 15.13% of total shares or a market value of ~£7.71m. This is a 2.9x multiple over the imputed book value carried by TEK for Belluscura (US$3.82m or ~£2.67m). This should increase TEK’s market cap by over £5.1m, providing a tangible basis for the asset valuation as well as a proof point underscoring its business model. It also demonstrates the reasonableness of TEK’s portfolio valuations writ large. As such, TEK should be trading closer to over £0.19/share if we add the asset value difference for Belluscura alone. Flagstaff
ptolemy
28/5/2021
08:51
Good morning Agreed ridicule and sells seem to be outweighing buys though one of the latter is my top up. Wait and see.
maytrees
28/5/2021
07:58
Amazed at no comment on today’s RNS! We have an $8.8m uplift in the book value of one of our investees and 17.1m shares in a newly listed company that will now be a public pointer to this element of TekCapital’s value, in line with Bellascura’s (bell) share price movements. Moreover, the TekCapital investment model has been proven. A great day for celebration!
ridicule
27/5/2021
08:59
Good morning What is so off putting about TEK is the huge spread between bid and offer. 15p - 16.5p I hold some ITX shares where the spread is currently 14.40p - 15p.
maytrees
26/5/2021
23:34
Are we expecting any new announcements at Fridays AGM? Is there a zoom/teams facility to dial into the AGM?
danmart2
26/5/2021
22:17
--USA study finds 70% of discharged Hospitalized Covid-19 patients have long COVID -- May 26th 2021 The study examined 45 other studies that were published between January 2020 and March 2021. The studies included more than 9,700 COVID-19 patients, of which 83% had been hospitalized. Fatigue (40%) and shortness of breath (36%) were the two most common symptoms hTtps://www.stanforddaily.com/2021/05/26/over-70-of-hospitalized-covid-19-patients-experience-long-haul-symptoms-landmark-stanford-study-finds/ The title of the study published 26th May 2021 was : Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 hTtps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2780376 The findings of the study were summarized as : Findings In this systematic review of 45 studies including 9751 participants with COVID-19, the median proportion of individuals who experienced at least 1 persistent symptom was 73%; symptoms occurring most frequently included shortness of breath or dyspnea, fatigue or exhaustion, and sleep disorders or insomnia. However, the studies were highly heterogeneous and needed longer follow-up and more standardized designs. buywell posits : The advent of the latest variant currently sweeping through India B.1.1617.2 and now present in more than 53 countries suggests that this variant will eclipse the UK dominant worldwide strain within the next two to three months . It already has in terms of numbers of cases in India alone BUT restricted testing ability of circa 2M/day in India has limited reported numbers. In a gene pool as large as India the numbers of mutations are now likely to accelerate based upon what has happened elsewhere to date plus further mutations in other countries as the different variants mix with other and swap chunks of DNA . The point being : long COVID is the elephant in the room that politiciancs don't want to talk about with present Covid-19 problems already swamping their healthcare systems. Whilst aerosol spread of Covid-19 continues unchecked due to lack of UVC disinfection in indoor settings --- so the numbers of long COVID cases rack up buywell has posted on here that around 2 Billion people will need oxygen therapy within a couple of years from today. Lack of clean UVC disinfected air strategies will imo ensure this is what happens. dyor
buywell2
26/5/2021
10:50
---- long COVID and Children another adverse outcome of New Variants ---- Children are now catching the latest mutations of Covid-19 These are at present unvaccinated and will continue to be so for many months to come in many countries as the push has been to vaccinate the elderly first and clinical tests for children and vaccines were very late in coming. The upshot is that many kids with undeveloped organs have suffered and are suffering organ damage htTps://www.aljazeera.com/features/2021/5/16/can-children-get-long-covid Around 500,000 kids in the UK have tested positive for Covid-19 and the B.1 1617.2 variant from India is now affecting the young and 20 to 30 year olds more so than other mutations hTtps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927578/ Evidence from the first study of long covid in children suggests that more than half of children aged between 6 and 16 years old who contract the virus have at least one symptom lasting more than 120 days, with 42.6 per cent impaired by these symptoms during daily activities. Sending thousands of children back to school is “insane”, says McFarland. “Sending children back to school seems to be inviting the possibility of giving a whole generation long-term chronic health issues. dyor
buywell2
26/5/2021
10:08
---- long COVID & New Study identifies ongoing oxygen requirements ---- 25th May 2021 NCIMI backed study confirms longer-term lung damage after COVID-19 “Many COVID-19 patients are still experiencing breathlessness several months after being discharged from hospital, despite their CT scans indicating that their lungs are functioning normally. Our follow-up scans using hyperpolarised xenon MRI have found that abnormalities not normally visible on regular scans are indeed present, and these abnormalities are preventing oxygen getting into the bloodstream as it should in all parts of the lungs.” A study by Oxford and Sheffield researchers backed by NCIMI using a cutting-edge has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for some patients even longer. This damage was not detected by routine CT scans and clinical tests, and the patients would consequently normally be told their lungs are normal. htTps://ncimi.co.uk/latest/study-confirms-longer-term-lung-damage-after-covid-19/ buywell adds : The inference of the above suggests that there is a huge number of discharged asymptomatic patients that were NOT treated in ICU's , that have lung damage but tests did not show them and one must assume they know something is not right because they are experiencing breathing difficulties . It has previously been thought that circa 20% of Covid-19 patients would suffer from long COVID That is olde hat --- Newer Variants are worse than those last year The study suggests that long COVID sufferers could be in excess of 50% if hyperpolarized 129Xe MRI (XeMRI) imaging technologies were to used --- and as high as 70% of case numbers hTtps://pubs.rsna.org/doi/10.1148/radiol.2021210033 Conclusion: A huge and growing market is now out there of long COVID sufferers that will need home oxygen therapy dyor
buywell2
Chat Pages: 71  70  69  68  67  66  65  64  63  62  61  60  Older
ADVFN Advertorial
Your Recent History
LSE
TEK
Tekcapital
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210614 15:51:13